Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from HeraMED Ltd. ( (AU:HMD) ) is now available.
HeraMED Ltd has lodged its updated corporate governance statement for the year ended 31 December 2025, confirming compliance with ASX Listing Rules that require disclosure of how it adheres to the ASX Corporate Governance Council’s recommendations. The company has outlined that it follows key governance practices, including a formal board charter, due diligence on director and executive appointments, written agreements for directors and senior executives, and direct board accountability for the company secretary, reinforcing its governance framework and transparency for shareholders.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Ltd is an ASX-listed company that operates in the healthcare technology sector. It focuses on digital health solutions and follows the ASX Corporate Governance Council’s principles and recommendations as part of its obligations as a listed entity.
Average Trading Volume: 742,026
Technical Sentiment Signal: Buy
Current Market Cap: A$41.21M
For an in-depth examination of HMD stock, go to TipRanks’ Overview page.